New Biomarkers Predict Outcome of Cancer Immunotherapy

News   Jan 10, 2018 | Original story from the University of Zurich

 
New Biomarkers Predict Outcome of Cancer Immunotherapy

Credit: National Cancer Institute \ Duncan Comprehensive Cancer Center at Baylor College of Medicine. Creator: Rita Elena Serda

 
 
 

RELATED ARTICLES

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Fraunhofer and Mologic Partner on Point-of-Care Diagnosis and Antibiotic Susceptibility Test for UTIs

News

Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance.

READ MORE

First Multiplex Test for Tick-Borne Diseases

News

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between Borrelia burgdorferi, the pathogen responsible for Lyme disease, and seven other tick-borne pathogens.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Diagnostics Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE